title: Treatment of cutaneous infections. Worldwide experience with ciprofloxacin.
abstract: Oral ciprofloxacin, a new fluorinated 4-quinolone, was evaluated in 795 patients with skin and skin structure infections. Ninety-four point one percent of the patients treated had clinical success with eradication of almost all of the offending bacteria. Ciprofloxacin has good activity against gram-positive organisms and excellent activity against gram-negative organisms. Side effects were few and not considered significant.
authors: Department of Dermatology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania.
authors: L C
authors: LC
authors: Parish
authors: J A
authors: JA
authors: Witkowski
authors: D L
authors: DL
authors: Jungkind
authors: R F
authors: RF
authors: Asper
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D002939:Ciprofloxacin / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D012874:Skin Diseases, Infectious / Q000188:drug therapy*
chemical_list: D002939:Ciprofloxacin